DK160611C - ANALOGY PROCEDURE FOR PREPARING 3,4-DISUBSTITUTED 1,2,5-THIADIAZOL-1-OXIDES AND -1,1-DIOXIDES - Google Patents

ANALOGY PROCEDURE FOR PREPARING 3,4-DISUBSTITUTED 1,2,5-THIADIAZOL-1-OXIDES AND -1,1-DIOXIDES

Info

Publication number
DK160611C
DK160611C DK371880A DK371880A DK160611C DK 160611 C DK160611 C DK 160611C DK 371880 A DK371880 A DK 371880A DK 371880 A DK371880 A DK 371880A DK 160611 C DK160611 C DK 160611C
Authority
DK
Denmark
Prior art keywords
dioxides
thiadiazol
disubstituted
oxides
preparing
Prior art date
Application number
DK371880A
Other languages
Danish (da)
Other versions
DK160611B (en
DK371880A (en
Inventor
Ronnie Ray Crenshaw
Aldo Antonio Algieri
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of DK371880A publication Critical patent/DK371880A/en
Publication of DK160611B publication Critical patent/DK160611B/en
Application granted granted Critical
Publication of DK160611C publication Critical patent/DK160611C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/08—1,2,5-Oxadiazoles; Hydrogenated 1,2,5-oxadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/40—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
DK371880A 1979-09-04 1980-09-01 ANALOGY PROCEDURE FOR PREPARING 3,4-DISUBSTITUTED 1,2,5-THIADIAZOL-1-OXIDES AND -1,1-DIOXIDES DK160611C (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US7251779A 1979-09-04 1979-09-04
US7251779 1979-09-04
US11718280A 1980-01-31 1980-01-31
US11718280 1980-01-31
US16383180A 1980-06-07 1980-06-07
US16383180 1980-06-07

Publications (3)

Publication Number Publication Date
DK371880A DK371880A (en) 1981-03-05
DK160611B DK160611B (en) 1991-04-02
DK160611C true DK160611C (en) 1991-09-16

Family

ID=27372107

Family Applications (4)

Application Number Title Priority Date Filing Date
DK371880A DK160611C (en) 1979-09-04 1980-09-01 ANALOGY PROCEDURE FOR PREPARING 3,4-DISUBSTITUTED 1,2,5-THIADIAZOL-1-OXIDES AND -1,1-DIOXIDES
DK269090A DK164700C (en) 1979-09-04 1990-11-09 3,4-DISUBSTITUTED 1,2,5-THIADIAZOL-1-OXIDES OR -1,1-DIOXIDES
DK268990A DK164363C (en) 1979-09-04 1990-11-09 3,4-DISUBSTITUTED 1,2,5-THIADIAZOL-1-OXIDES
DK269190A DK164702C (en) 1979-09-04 1990-11-09 3,4-DISUBSTITUTED 1,2,5-THIADIAZOL-1-OXIDES OR -1,1-DIOXIDES

Family Applications After (3)

Application Number Title Priority Date Filing Date
DK269090A DK164700C (en) 1979-09-04 1990-11-09 3,4-DISUBSTITUTED 1,2,5-THIADIAZOL-1-OXIDES OR -1,1-DIOXIDES
DK268990A DK164363C (en) 1979-09-04 1990-11-09 3,4-DISUBSTITUTED 1,2,5-THIADIAZOL-1-OXIDES
DK269190A DK164702C (en) 1979-09-04 1990-11-09 3,4-DISUBSTITUTED 1,2,5-THIADIAZOL-1-OXIDES OR -1,1-DIOXIDES

Country Status (23)

Country Link
US (1) US4374248A (en)
AR (1) AR240559A1 (en)
AT (2) AT376978B (en)
CA (4) CA1167841A (en)
CH (2) CH658055A5 (en)
CS (1) CS235951B2 (en)
CY (2) CY1360A (en)
DE (2) DE3051146C2 (en)
DK (4) DK160611C (en)
FI (1) FI76795C (en)
GB (2) GB2067987B (en)
HK (2) HK41387A (en)
IE (2) IE50997B1 (en)
KE (2) KE3685A (en)
LU (1) LU82753A1 (en)
MY (2) MY8700735A (en)
NL (3) NL189197C (en)
NO (4) NO160003C (en)
NZ (1) NZ194831A (en)
PT (1) PT71764B (en)
SE (5) SE449099B (en)
SG (1) SG61187G (en)
ZW (1) ZW20580A1 (en)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0040696B1 (en) * 1980-04-30 1986-08-27 Merck & Co. Inc. Aminothiadiazoles as gastric secretion inhibitors
US4904792A (en) * 1980-10-02 1990-02-27 Eli Lilly And Company N-thiazolymethylthioalkyl-N'-alkylamidines and related compounds
US4760075A (en) * 1980-10-02 1988-07-26 Eli Lilly And Company N-thiazolylmethylthioalkyl-N-alkyl-amidines and related compounds
US4471122A (en) * 1981-03-03 1984-09-11 Bristol-Myers Company Thiadiazole histamine H2 -antagonists
EP0065823A1 (en) * 1981-05-13 1982-12-01 Imperial Chemical Industries Plc Heterocyclic guanidines as histamine H-2 antagonists
IE53068B1 (en) * 1981-06-15 1988-05-25 Merck & Co Inc Diamino isothiazole-1-oxides and -1,1-dioxides as gastic secretion inhibitors
ATE19880T1 (en) * 1981-08-24 1986-06-15 Merck & Co Inc THIDIAZOLE OXIDES WITH ANTISECRETORY ACTION.
GR77847B (en) * 1981-12-14 1984-09-25 American Home Prod
US4528377A (en) * 1982-03-29 1985-07-09 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4528378A (en) * 1982-03-29 1985-07-09 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
NL8301063A (en) * 1982-03-29 1983-10-17 Bristol Myers Co SUBSTITUTED 3,4-DIAMINO-1,2,5-THIADIAZOLS WITH HISTAMINE H2 RECEPTOR ANTAGONISTIC EFFICACY; SUBSTITUTED ETHHANE DIIMIDAMIDS.
US4528375A (en) * 1982-03-29 1985-07-09 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4517366A (en) * 1982-03-29 1985-05-14 Bristol-Myers Company Intermediates for preparing 3,4-diamino-1,2,5-thiadiazoles
US4578471A (en) * 1982-03-29 1986-03-25 Bristol-Myers Company Substituted amino alkyl pyridyl ethanediimidamides
FI832519L (en) * 1982-07-12 1984-01-13 Bristol Myers Co PHARMACEUTICAL FORMS AND SAMPLES
US4520025A (en) * 1982-07-21 1985-05-28 William H. Rorer, Inc. Bicyclic nitrogen heterocyclic ethers and thioethers, and their pharmaceutical uses
EP0105732A3 (en) * 1982-10-01 1985-09-04 Beecham Group Plc Histamine h2 receptor antagonists of the benzisothiazole amino and benzthiadiazine amino series
US4461900A (en) * 1983-03-14 1984-07-24 American Home Products Corporation 4,5-Dihydrothiadiazole 1,1-dioxide derivatives
US4440933A (en) * 1983-03-16 1984-04-03 Bristol-Myers Company Process for preparing 1,2,5-thiadiazoles
AT387384B (en) * 1983-03-16 1989-01-10 Bristol Myers Co METHOD FOR PRODUCING THIADIAZOLE DERIVATIVES
AU563072B2 (en) * 1983-04-26 1987-06-25 Shionogi & Co., Ltd. 2-guanidino-4-hydroxymethylthiazole and derivitives thereof
US4543352A (en) * 1983-04-29 1985-09-24 William H. Rorer, Inc. Naphthalene aminoalkylene ethers and thioethers, and their pharmaceutical uses
DE3326545A1 (en) * 1983-07-22 1985-01-31 Ludwig Heumann & Co GmbH, 8500 Nürnberg PROPAN-2-OL DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
US4529731A (en) * 1983-09-22 1985-07-16 American Home Products Corporation Thiadiazolediamine derivative with histamine H-2 receptor inhibiting properties
US4692531A (en) * 1984-06-22 1987-09-08 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4644006A (en) * 1984-06-22 1987-02-17 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4612309A (en) * 1984-10-23 1986-09-16 William H. Rorer, Inc. Antisecretory bicyclic benzo-oxy heterocyclic ethers and thioethers
GB8501535D0 (en) * 1985-01-22 1985-02-20 Smith Kline French Lab Chemical compounds
US4728648A (en) * 1985-02-09 1988-03-01 Smith Kline & French Laboratories Limited Histamine antagonist triadiazole derivatives, compositions, and method of use therefor
GB8509276D0 (en) * 1985-04-11 1985-05-15 Smith Kline French Lab Pyridine derivatives
GB8510680D0 (en) * 1985-04-26 1985-06-05 Smith Kline French Lab Pyridine derivatives
CA1286297C (en) * 1985-06-13 1991-07-16 George S. Sach Pyridine derivatives
DE3532880A1 (en) * 1985-09-14 1987-03-26 Basf Ag 1,4-DISUBSTITUTED PYRAZOLE DERIVATIVES
GB8610867D0 (en) * 1986-05-02 1986-06-11 Smith Kline French Lab 3-hydroxypyridines
ES2008962A6 (en) * 1987-12-17 1989-08-16 Marga Investigacion New-quanidino-thiazol compounds, their preparation, and use as intermediates of famotidine process.
ATE197296T1 (en) * 1991-05-21 2000-11-15 Lilly Co Eli METHOD FOR PREPARING INTERMEDIATE PRODUCTS FOR NIZATIDINE AND RELATED COMPOUNDS
US5248673A (en) * 1992-12-23 1993-09-28 Bristol-Myers Squibb Co. Bisamidine derivatives as thrombin inhibitors
US5929247A (en) * 1994-10-24 1999-07-27 Eli Lilly And Company Heterocyclic compounds and their preparation and use
US5618816A (en) * 1995-03-02 1997-04-08 Bristol-Myers Squibb Company Antimigraine 1,2,5-thiadiazole derivatives of indolylalkyl-pyridnyl and pyrimidinylpiperazines
US5767280A (en) * 1995-06-01 1998-06-16 Eli Lilly And Company Process for making heterocyclic compounds
DE60326080D1 (en) 2002-10-09 2009-03-19 Schering Corp Thiadiazoldioxide und thiadiazoloxide als cxc- und cc-chemokinrezeptor liganden
DE602004016211D1 (en) 2003-12-19 2008-10-09 Schering Corp Thiadiazole als cxc- und cc-chemokinrezeptorliganden
EP1697354B1 (en) 2003-12-22 2013-08-07 Merck Sharp & Dohme Corp. Isothiazole dioxides as cxc- and cc- chemokine receptor ligands
CN101253180B (en) 2005-06-29 2011-08-03 先灵公司 5,6-di-substituted oxadiazolopyrazines and thiadiazolopyrazines as CXC-chemokine receptor ligands
WO2007002764A2 (en) 2005-06-29 2007-01-04 Schering Corporation Di-substituted oxadiazoles as cxc-chemokine receptor ligands
US9505728B2 (en) 2012-03-09 2016-11-29 Inception 2, Inc. Triazolone compounds and uses thereof
WO2014009293A1 (en) 2012-07-13 2014-01-16 Basf Se New substituted thiadiazoles and their use as fungicides
AU2013363398B2 (en) 2012-12-20 2017-06-01 Tempest Therapeutics, Inc. Triazolone compounds and uses thereof
EA201690230A1 (en) 2013-09-06 2016-07-29 Инсепшн 2, Инк. TRIAZOLONE COMPOUNDS AND THEIR APPLICATIONS
CN105061360B (en) * 2015-07-28 2018-06-19 首都师范大学 A kind of 3,4- diaminostilbenes, the method for purification of 2,5- thiadiazoles
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL22850A (en) * 1964-03-18 1968-12-26 Merck & Co Inc 3-chloro-1,2,5-thiazdiazole-4-carboxylic acid being an intermediate in the preparation of sulfa drugs
CH482712A (en) * 1964-10-01 1969-12-15 Merck & Co Inc Process for the preparation of 3-amino-1,2,5-thiadiazoles
US3564000A (en) * 1965-10-15 1971-02-16 Merck & Co Inc Process for preparing 3-chloro-4-hydroxy-1,2,5-thiadiazole derivatives
US3419573A (en) * 1965-10-15 1968-12-31 Merck & Co Inc 3-chloro-4-oxy-1,2,5-thiadiazoles, and a process for preparing same
DE1770152A1 (en) * 1968-04-08 1971-09-30 Lentia Gmbh Process for the preparation of 3-amino-4-bromo-1,2,5-thiadiazole
US3657237A (en) * 1968-05-22 1972-04-18 Frosst & Co Charles E Process for making 1 2 5-thiadiazoles in the sinister configuration
US4104381A (en) * 1973-05-03 1978-08-01 Smith Kline & French Laboratories Limited Pharmacologically active compounds
AT348517B (en) * 1977-01-19 1979-02-26 Chemie Linz Ag PROCESS FOR THE PREPARATION OF PURE 3-METHOXY-4- (4'-AMINOBENZOLSULFONAMIDO) -1,2,5-THIADIAZOLE
ZA782129B (en) * 1977-04-20 1979-03-28 Ici Ltd Hertocyclic derivatives
US4165378A (en) * 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles
US4374836A (en) * 1978-10-16 1983-02-22 Imperial Chemical Industries Ltd. Antisecretory heterocyclic derivatives, process for their manufacture and pharmaceutical compositions containing them
EP0040696B1 (en) * 1980-04-30 1986-08-27 Merck & Co. Inc. Aminothiadiazoles as gastric secretion inhibitors
EP0045155B1 (en) * 1980-07-30 1985-01-02 Imperial Chemical Industries Plc Guanidine derivatives
ATE19880T1 (en) * 1981-08-24 1986-06-15 Merck & Co Inc THIDIAZOLE OXIDES WITH ANTISECRETORY ACTION.

Also Published As

Publication number Publication date
SE8403111L (en) 1984-06-08
MY8700735A (en) 1987-12-31
CA1248962A (en) 1989-01-17
SE8403109D0 (en) 1984-06-08
DK164363B (en) 1992-06-15
SE456582B (en) 1988-10-17
PT71764B (en) 1983-04-28
DK164702C (en) 1992-12-21
FI76795B (en) 1988-08-31
NO160781B (en) 1989-02-20
DK269090D0 (en) 1990-11-09
CH649764A5 (en) 1985-06-14
NO862501D0 (en) 1986-06-23
NZ194831A (en) 1984-11-09
ZW20580A1 (en) 1981-01-21
GB8318949D0 (en) 1983-08-17
NO160003B (en) 1988-11-21
AR240559A1 (en) 1990-05-31
SE8403108L (en) 1984-06-08
CY1402A (en) 1987-12-18
DK268990D0 (en) 1990-11-09
NL189197C (en) 1993-02-01
IE801851L (en) 1981-03-04
IE51235B1 (en) 1986-11-12
ATA64584A (en) 1984-07-15
NL9201236A (en) 1993-03-01
HK89187A (en) 1987-12-11
CA1263115A (en) 1989-11-21
IE861175L (en) 1981-03-04
DE3033169A1 (en) 1981-03-19
SE8403107D0 (en) 1984-06-08
MY8700585A (en) 1987-12-31
DK164700C (en) 1992-12-21
LU82753A1 (en) 1981-04-17
DE3051146C2 (en) 1991-05-02
DK164700B (en) 1992-08-03
NO160003C (en) 1989-03-01
NL8004967A (en) 1981-03-06
SE8403109L (en) 1984-06-08
KE3742A (en) 1987-09-04
SE461733B (en) 1990-03-19
NO871421D0 (en) 1987-04-06
IE50997B1 (en) 1986-09-03
NL189197B (en) 1992-09-01
DK164702B (en) 1992-08-03
DE3033169C2 (en) 1989-08-03
CS235951B2 (en) 1985-05-15
GB2067987A (en) 1981-08-05
HK41387A (en) 1987-06-05
DK268990A (en) 1990-11-09
SE456580B (en) 1988-10-17
SE8403108D0 (en) 1984-06-08
CY1360A (en) 1987-08-07
US4374248A (en) 1983-02-15
NO160781C (en) 1989-05-31
AT376978B (en) 1985-01-25
GB2132190B (en) 1985-01-03
NO802576L (en) 1981-03-05
NO862501L (en) 1987-03-05
CA1263114A (en) 1989-11-21
AT377257B (en) 1985-02-25
SE8403107L (en) 1984-06-08
GB2067987B (en) 1984-07-11
NO161737C (en) 1989-09-20
SE8006148L (en) 1981-04-15
NO161737B (en) 1989-06-12
DK160611B (en) 1991-04-02
SE449099B (en) 1987-04-06
SG61187G (en) 1987-10-23
DK164363C (en) 1992-11-02
DK269090A (en) 1990-11-09
SE456581B (en) 1988-10-17
NO871420D0 (en) 1987-04-06
CA1167841A (en) 1984-05-22
CH658055A5 (en) 1986-10-15
FI76795C (en) 1988-12-12
SE8403111D0 (en) 1984-06-08
NO162664B (en) 1989-10-23
DK371880A (en) 1981-03-05
FI802740A (en) 1981-03-05
GB2132190A (en) 1984-07-04
NO162664C (en) 1990-01-31
KE3685A (en) 1987-01-30
DK269190D0 (en) 1990-11-09
ATA443480A (en) 1984-06-15
NL9201237A (en) 1993-03-01
DK269190A (en) 1990-11-09
PT71764A (en) 1980-09-30

Similar Documents

Publication Publication Date Title
DK160611C (en) ANALOGY PROCEDURE FOR PREPARING 3,4-DISUBSTITUTED 1,2,5-THIADIAZOL-1-OXIDES AND -1,1-DIOXIDES
DK153552C (en) ANALOGY PROCEDURE FOR PREPARING 1,8-NAPHTHYRIDE INGREDIATES
DK149749C (en) ANALOGY PROCEDURE FOR PREPARING N-ALKYL-2-HYDROXY-METHYL-3,4,5-TRIHYDROXY-PIPERIDE INGREDIATES
DK159442C (en) ANALOGY PROCEDURE FOR PREPARING 6,7-SUBSTITUTED-4-ETHYL-QUINAZOLINES
DK157019C (en) ANALOGY PROCEDURE FOR PREPARING 2-AMINO-4-HYDROXYQUINAZOLINE DERIVATIVES
DK151252C (en) ANALOGY PROCEDURE FOR PREPARING 3-ALKYLTIO-4-OXOQUINOLINE COMPOUNDS
DK469379A (en) PROCEDURE FOR PREPARING 1-HYDROXYLERED 5,6-VITAMIND COMPOUNDS
DK153844C (en) ANALOGY PROCEDURE FOR PREPARING 1,2,3,5-TETRAHYDROIMIDAZOTHIENOPYRIMIDIN-2-ONER
DK243477A (en) PROCEDURE FOR THE PREPARATION OF 10,19-DIHYDROVITAMIN D COMPOUNDS
DK156635C (en) ANALOGY PROCEDURE FOR PREPARING 24,24-DIFLUOR-25-HYDROXYCHOLECALCIFEROL
DK150511C (en) METHOD FOR PREPARING 3,4-DI-HYDRO-4-OXO-2H-1,2-BENZOTHIAZINE-3-CARBOXAMIDE-1,1-DIOXIDE COMPOUNDS
DK301277A (en) PROCEDURE FOR PREPARING SUBSTITUTED 2,6-METHANO-2H-1-BENZOXOCINES
DK154136C (en) ANALOGY PROCEDURE FOR PREPARING 2-AMINO-3-BENZOYLPHENYLACETAMIDES
DK148302C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF 1,3-DIALKYLXANTHININ DERIVATIVES
DK153838C (en) ANALOGY PROCEDURE FOR PREPARING 2,4-DICHLOR-ALFA- (N-IMIDAZOLYLMETHYL) -DIBENZYLETHERS
DK395877A (en) PROCEDURE FOR MAKING 2- (4-AROYLPIPERAZIN-1-YL) -4-AMINO-6,7-DIMETHOXYQUINAZOLINES
DK375380A (en) METHOD FOR PREPARING 5- (CHLORPHENYL) -6H-1,3,4-THIADIAZIN-2-AMINES
DK150299C (en) ANALOGY PROCEDURE FOR PREPARING 8-AMINOALKYL-TETRACYCLO (4,3,0,02,4,03,7) NONANDER DERIVATIVES
DK146067C (en) ANALOGY PROCEDURE FOR PREPARING 2,4-DIAMINO-5-PHENOXYPROPOXYPYRIMIDINES
DK365879A (en) METHOD FOR PREPARING 4-HYDROXY-2H (1) BENZOTHENO (, 3 -) - 1,2-THIAZIN-3-CARBOXAMIDE-1,1-DIOXIDES
DK105178A (en) PROCEDURE FOR PREPARING 2,1,3-THIADIAZIN-4-ON-2,2-DIOXIDE DERIVATIVES
DK140578A (en) PROCEDURE FOR MAKING 2- (2!, 2!, - TRIHALOGENETHYL) -4-HALOGENCYCLOBUTAN-1-ONERS.
DK48478A (en) PROCEDURE FOR THE PREPARATION OF 2,5-DIHYDRO-1,2-THIAZINO (5,6-B) INDOL-3-CARBOXAMIDE-1,1-DIOXIDES
DK147069C (en) ANALOGY PROCEDURE FOR PREPARING 1,6-DIMESYL-3,4-DIMETHYL-D-MANNITOL
DK549979A (en) METHOD FOR PREPARING 7-CHLOR-2-METHYL-3,3A-DIHYDRO-2H, 9H-ISOXAZOLO- (3,2-B) -1,3-BENZOXAZIN-9-ON

Legal Events

Date Code Title Description
PBP Patent lapsed